Endoscopic stenting and concurrent chemoradiotherapy for advanced esophageal cancer: A case-control study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

392

HTML

2738

Figures (1-1)

219

Tables (1-5)

308

Sum=3657

Mar 28, 2012 (publication date) through Nov 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 28, 2012; 18(12): 1404-1409
Published online Mar 28, 2012. doi: 10.3748/wjg.v18.i12.1404

Table 4 Comparison of clinical and survival outcomes between 3-dimensional conformal and control groups

Outcome	3D-CRT (n = 67)	Control (n = 32)
Median survival (d)	251.7	91.1
Overall survival at a half year	91%	50%
Over survival at 1 year	25%	0
Total hospital stay (mean ± SD, d)	146 ± 48	87 ± 29
Median hospitalization-free survival (mean ± SD, d)	186 ± 33	59 ± 18

3D-CRT: 3-dimensional conformal chemoradiotherapy.

Citation: Jiang XJ, Song MQ, Xin YN, Gao YQ, Niu ZY, Tian ZB. Endoscopic stenting and concurrent chemoradiotherapy for advanced esophageal cancer: A case-control study. World J Gastroenterol 2012; 18(12): 1404-1409
URL: https://www.wjgnet.com/1007-9327/full/v18/i12/1404.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i12.1404